DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
Clinical trial NCT03059485 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03059485
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2026-09-04
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.